<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT: MAY 26, 1999
NETMED, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
Ohio 1-12529 31-1282391
- --------------- --------------------- -------------
(STATE OR OTHER (COMMISSION FILE NO.) (IRS EMPLOYER
JURISDICTION OF IDENTIFICATION)
NUMBER)
INCORPORATION OR
ORGANIZATION)
6189 Memorial Drive
Dublin, Ohio 43017
(614) 793-9356
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER
INCLUDING AREA CODE OF REGISTRANT'S
PRINCIPAL EXECUTIVE OFFICES)
Not Applicable
(FORMER NAME OR FORMER ADDRESS, IF CHANGED SINCE LAST REPORT)
<PAGE> 2
ITEM 5. OTHER EVENTS.
On May 26, 1999, NetMed, Inc., an Ohio corporation (the "Company"),
announced that David J. Richards has resigned as Chairman and CEO of the Company
and that James F. Zid has been elected Chairman and Trevor Ferger has been
elected President and CEO. The press release is included as Exhibit 99 to this
Form 8-K and is incorporated herein by this reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
Exhibit No. Description
99 Press release of NetMed, Inc., issued March 11, 1999,
regarding management changes.
-2-
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NETMED, INC.
Date: May 27, 1999 By: /s/ Trevor Ferger
-------------------------------------
Trever Ferger, President and CEO
-3-
<PAGE> 4
EXHIBIT INDEX
Exhibit No. Description
99 Press release of NetMed, Inc., issued May 26, 1999,
regarding management changes.
-4-
<PAGE> 1
EXHIBIT 99
FOR MORE INFORATION CONTACT: Trevor Ferger, CEO (614) 793-9356, OR
http://www.ntmed.com
FOR IMMEDIATE RELEASE
NETMED ANNOUNCES MANAGEMENT CHANGES
DUBLIN, OH, May 26, 1999 - NetMed, Inc. (OTCBB:NTMD) today announced that David
J. Richards resigned as Chairman and CEO of the Company, and from its Board of
Directors, and that the Board had elected James F. Zid as Chairman, and Trevor
Ferger as President and CEO.
"NetMed has many challenges, both financial and in product development," said
Ferger. "It is our goal to put the Company on firm financial footing and
continue the development of the OxyNet(R) oxygen concentrator."
NetMed is in the business of developing and marketing medical technology. It
recently lost its license to market the Papnet(R) system of automated Pap smear
screening as a result of the bankruptcy reorganization of the licensor,
Neuromedical Systems, Inc. NetMed, through its OxyNet subsidiary, is currently
developing the OxyNet(R) oxygen concentration device, which the Company is
developing for the home healthcare and other markets.
SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
Statements in this release which relate to other than strictly historical facts,
including statements about the Company's plans and strategies, as well as
management's expectations about new and existing products, technologies and
opportunities, market growth, demand for and acceptance of new and existing
products, are forward looking statements. The words "believe," "expect,"
"anticipate," "estimate," "project," and similar expressions identify
forward-looking statements that speak only as of the date hereof. Investors are
cautioned that such statements involve risks and uncertainties that could cause
actual results to differ materially from historical or anticipated results due
to many factors including, but are not limited to, continuing losses from
operations and negative cash flow, the challenges of research and development of
new products, and other risks detailed in the Company's most recent Annual
Report on Form 10-K and other Securities and Exchange Commission filings. The
company undertakes no obligation to publicly update or revise any
forward-looking statements.
